Llwytho...
Drug-Induced Thrombotic Microangiopathy due to Cumulative Toxicity of Ixazomib
Drug-induced thrombotic microangiopathies (DTMAs) are increasingly being recognized as an important category of thrombotic microangiopathies (TMAs). Cancer therapeutic agents including proteasome inhibitors (PIs) are among the most common medications reported to cause DTMA. PIs could cause DTMA eith...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Case Rep Hematol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Hindawi
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6051099/ https://ncbi.nlm.nih.gov/pubmed/30057831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7063145 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|